Trials / Completed
CompletedNCT04084925
HOMA-IR as a Screening Test in NAFLD
Is HOMA-IR(Homeostatic Model Assessment for Insulin Resistance) a Potential Screening Test for Non-alcoholic Fatty Liver Disease in Adults With Type 2 DM?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Fayoum University · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the role of HOMA-IR in diagnosis of NAFLD in patients with type 2 DM.
Detailed description
this study is a retrospective cohort study included 100 patients with type 2 DM from the outpatient clinic of internal medicine department at Fayoum University Hospital. They were divided into two equal groups according to the presence of NAFLD by ultrasound. All patients were subjected to history taking, clinical examination and investigations which included: ALT, AST, total cholesterol, TG, FBG and fasting insulin level,HOMA-IR(Homeostatic Model Assessment for Insulin Resistance) assessment.
Conditions
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2018-06-20
- Completion
- 2018-12-20
- First posted
- 2019-09-10
- Last updated
- 2019-09-12
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04084925. Inclusion in this directory is not an endorsement.